PMID: 8963042Sep 1, 1995Paper

Interferon treatment for chronic hepatitis C in haemodialysis patients: suggestions based on a small series

Journal of Gastroenterology and Hepatology
K OkudaY Irie

Abstract

Chronic hepatitis C is endemic among chronic haemodialysis patients. There have been a number of reports on hepatocellular carcinoma developing in such patients in Japan. The present study reports on the treatment of 15 patients who showed elevated ALT levels due to biopsy proven chronic hepatitis C with interferon alpha-2a (IFN). The dose schedule was 6 mega units (MU) daily for the first two weeks followed by 3 doses per week for 5.5 months. Side effects were so severe that IFN treatment was discontinued early in one patient, the dosage reduced in 11 and only tolerated in the original schedule by three patients. Excluding one patient who only recently completed the therapy, 13 were able to be evaluated for therapy efficacy by assessment of serum ALT and viral RNA. The overall results showed that IFN was effective in eight of 13 patients, a rate somewhat higher than the reported figures in this country. It is concluded that IFN therapy is indicated in haemodialysis patients with progressive chronic hepatitis C, but the dose administered should be lower and the dose schedule more flexible, perhaps 3 MU three times a week, in order to minimize untoward side effects.

References

Jul 1, 1992·The European Journal of Medicine·P Marcellin
Feb 1, 1992·Annals of the Rheumatic Diseases·C M Weyand, J J Goronzy
Nov 1, 1991·Journal of Hepatology·P J Scheuer
Jun 15, 1990·Annals of Internal Medicine·J B ZeldisP V Holland
Dec 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C CarameloM P Garrón
May 1, 1995·Journal of Gastroenterology and Hepatology·Y TauraT Sato
Mar 1, 1994·Journal of Gastroenterology and Hepatology·K ChayamaM Kobayashi
Feb 20, 1993·Lancet·S BrillantiL Barbara

❮ Previous
Next ❯

Citations

Sep 25, 2002·Transplantation Proceedings·D Van ThielN Shah
Oct 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Catherine M MeyersJay H Hoofnagle
Sep 26, 2001·Infectious Disease Clinics of North America·S L Zacks, M W Fried
Nov 5, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·A GotohS Kamidono
Jul 26, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Craig E GordonJohn B Wong
Aug 1, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Craig E GordonJohn B Wong
Mar 20, 2010·Digestive Diseases and Sciences·Sorin A PetreVijayan Balan
Jan 25, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Craig E GordonJohn B Wong
Feb 23, 2008·La Presse médicale·Nabil Ben ChaabaneHammouda Saffar
Jul 23, 2003·The American Journal of Gastroenterology·Mark W RussoRobert S Brown
Jul 28, 2004·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Motoko TanakaKimio Tomita
Sep 18, 2008·The American Journal of Gastroenterology·Emuejevoke J OkohStephen A Harrison
Sep 16, 1998·Journal of Gastroenterology and Hepatology·K OkudaY Irie
Jan 4, 1998·Journal of Gastroenterology and Hepatology·C C Huang
Nov 18, 1998·Current Opinion in Nephrology and Hypertension·J M Diego, D Roth
Jul 20, 2004·World Journal of Gastroenterology : WJG·Kunio Okuda, Osamu Yokosuka
Jan 10, 2003·The International Journal of Artificial Organs·S BunnapradistS Jordan
Dec 5, 2003·Alimentary Pharmacology & Therapeutics·F FabriziP Martin
Sep 27, 2000·Journal of the American Society of Nephrology : JASN·Eijun NakayamaChifumi Sato

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.